The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.
 
Yehia I. Abugabal
No Relationships to Disclose
 
Aliya Qayyum
No Relationships to Disclose
 
Manal Hassan
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Dan G. Duda
No Relationships to Disclose
 
Rikita Hatia
No Relationships to Disclose
 
Sunyoung S. Lee
No Relationships to Disclose
 
Robert A. Wolff
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.; Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.; Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.; Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Roberto Pestana
No Relationships to Disclose
 
Jeffrey Morris
No Relationships to Disclose
 
James C. Yao
No Relationships to Disclose
 
Hesham M. Amin
No Relationships to Disclose
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences
Honoraria - Bayer Health; Bayer Health; Bayer Health; Bayer Health; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Consulting or Advisory Role - Bayer Health; Bayer Health; Bayer Health; Bayer Health; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Research Funding - Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck